ABUJA, NIGERIA — The World Health Organization (WHO) has issued a regional public health alert across West Africa after confirming 67 laboratory-confirmed cases of Yellow Fever and 18 deaths across nine African nations.
According to WHO epidemiological data covering the reporting period between January 1 and October 12, 2026, Nigeria recorded four confirmed cases and one fatality.
1. Regional Breakdown & Affected Countries
The disease outbreak has affected nine countries in the WHO African Region, with the heaviest burden concentrated along West African border corridors:
- Côte d’Ivoire: 30 confirmed cases, 10 deaths
- Burkina Faso: 15 confirmed cases, 3 deaths
- Cameroon: 9 confirmed cases, 1 death
- Ghana: 4 confirmed cases, 3 deaths
- Nigeria: 4 confirmed cases, 1 death
- Central African Republic (CAR): 2 confirmed cases, 0 deaths
- Guinea, Liberia & Togo: 1 confirmed case each
WHO evaluated the regional public health risk as moderate due to frequent cross-border movements, agricultural and mining activities near forest edges, and gaps in routine immunization coverage. However, global public health risk remains low.
2. Vulnerability Factors & Transmission Risks
Public health experts highlight several factors accelerating the spread of the mosquito-borne virus:
- High-Risk Populations: Unvaccinated individuals, forest-edge agricultural workers, miners, and cross-border traders face the highest exposure risks.
- Vector Transmission: The primary vector, Aedes mosquitoes, breeds in both urban containers and rural/forest environments, facilitating transmission between wild and human populations.
- Diagnostic Delay: Regional sample referrals to accredited reference laboratories (such as the Institut Pasteur in Dakar) can delay rapid case confirmations in remote areas.
3. Prevention, Vaccination & Preventive Measures
Health authorities emphasize that Yellow Fever is preventable through active immunization:
- Single-Dose Lifetime Protection: A single dose of the yellow fever vaccine provides lifelong immunity without requiring a booster shot.
- Supportive Care: There is no specific antiviral treatment for Yellow Fever; medical management relies on supportive clinical care.
- Travel Advisory: WHO advises all international travelers aged 9 months and older visiting at-risk regions to obtain a valid Yellow Fever vaccination certificate prior to travel.
Comments
Post a Comment